Panagora Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Panagora Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,318	Closed	-$1.34M	–	2835
2021 Q2	$1.34M	Sell	7,318 -807	-10%	-$139K	0.01%	876
2021 Q1	$1.24M	Sell	8,125 -34	-0.4%	-$5.26K	0.01%	932
2020 Q4	$1.27M	Sell	8,159 -12,411	-60%	-$1.59M	0.01%	873
2020 Q3	$2.35M	Sell	20,570 -91	-0.4%	-$9.82K	0.01%	576
2020 Q2	$2.32M	Buy	20,661 +320	+2%	+$34K	0.01%	614
2020 Q1	$1.83M	Sell	20,341 -1,740	-8%	-$171K	0.01%	621
2019 Q4	$2.39M	Sell	22,081 -142,152	-87%	-$15.2M	0.01%	718
2019 Q3	$16.1M	Buy	164,233 +140,594	+595%	+$15.8M	0.07%	247
2019 Q2	$3.1M	Sell	23,639 -70,221	-75%	-$9.05M	0.01%	655
2019 Q1	$12.7M	Buy	93,860 +86,899	+1,248%	+$10.8M	0.06%	308
2018 Q4	$678K	Sell	6,961 -71,066	-91%	-$8.4M	﹤0.01%	1235
2018 Q3	$10.8M	Sell	78,027 -3,209	-4%	-$403K	0.04%	348
2018 Q2	$10.1M	Sell	81,236 -11,415	-12%	-$1.33M	0.04%	347
2018 Q1	$10.3M	Buy	92,651 +83,677	+932%	+$10M	0.04%	355
2017 Q4	$1.07M	Sell	8,974 -6,013	-40%	-$732K	﹤0.01%	1111
2017 Q3	$2.1M	Buy	14,987 +5,515	+58%	+$749K	0.01%	842
2017 Q2	$1.15M	Buy	9,472 +812	+9%	+$94.5K	﹤0.01%	1061
2017 Q1	$1.05M	Sell	8,660 -1,125	-11%	-$145K	﹤0.01%	1123
2016 Q4	$1.2M	Sell	9,785 -1,304	-12%	-$160K	0.01%	1126
2016 Q3	$1.36M	Buy	11,089 +1,464	+15%	+$188K	0.01%	1073
2016 Q2	$1.12M	Buy	9,625 +451	+5%	+$64K	0.01%	1083
2016 Q1	$1.28M	Buy	9,174 +2,787	+44%	+$409K	0.01%	1007
2015 Q4	$1.22M	Sell	6,387 -380	-6%	-$66.4K	0.01%	988
2015 Q3	$1.06M	Sell	6,767 -987	-13%	-$180K	0.01%	1020
2015 Q2	$1.4M	Hold	7,754	–	–	0.01%	948
2015 Q1	$1.34M	Sell	7,754 -915	-11%	-$166K	0.01%	948
2014 Q4	$1.6M	Buy	8,669 +612	+8%	+$113K	0.01%	822
2014 Q3	$1.34M	Sell	8,057 -1,607	-17%	-$264K	0.01%	910
2014 Q2	$1.51M	Sell	9,664 -9,845	-50%	-$1.55M	0.01%	913
2014 Q1	$2.97M	Buy	19,509 +6,147	+46%	+$977K	0.01%	722
2013 Q4	$1.78M	Buy	13,362 +1,130	+9%	+$136K	0.01%	921
2013 Q3	$1.42M	Sell	12,232 -9,027	-42%	-$990K	0.01%	959
2013 Q2	$1.96M	Buy	+21,259	New	+$2.05M	0.01%	787

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return